The National Cancer Society Malaysia (NCSM) is urging the country to adopt a national co-screening strategy to address the rising prevalence of cardio-renal-metabolic (CRM) conditions, a group of interconnected diseases that include cardiovascular disease, chronic kidney disease, and metabolic disorders such as diabetes. By shifting from managing individual diseases separately to an integrated screening model, the organization suggests that health systems can better manage the overlapping risks that often drive these conditions to worsen in tandem. This approach aims to address the significant hidden burden of chronic disease currently observed in populations where fragmented care may lead to delayed interventions.
The Case for Integrated Cardio-Renal-Metabolic Screening
The push for co-screening stems from the clinical reality that heart, kidney, and metabolic functions are deeply intertwined. According to the NCSM, these conditions share many of the same risk factors and often develop together, with each condition increasing the likelihood and severity of the others. Current healthcare approaches, however, often treat heart, kidney and metabolic diseases separately, which can result in missed opportunities to detect overlapping health risks early and fragmented follow-up care.
Recent community-based screenings in Malaysia have provided data suggesting that a large portion of the population may be living with undiagnosed risks. Data from the NCSM-Boehringer Ingelheim Saring@Komuniti Project, conducted last year with support from the health ministry, revealed that 97.8% of 5,000 participants from underserved communities in the Klang Valley exhibited at least one CRM risk factor. Among those screened, 41.3% were obese, 28.8% were overweight, 34.5% had pre-diabetes and 35.1% had diabetes.
These findings highlight a significant gap between routine health checks and the comprehensive care required to manage CRM diseases effectively. Dr Murallitharan Munisamy, managing director of the NCSM, has emphasized that the current reliance on managing diseases separately is no longer sufficient. He noted that Malaysia has an opportunity to address cardiovascular, kidney and metabolic health as a “connected continuum,” rather than as disparate clinical events.
Addressing the Growing Burden of Chronic Disease
The rise in chronic health conditions is a documented public health challenge. In Malaysia, the prevalence of chronic kidney disease rose from 9.1% in 2011 to 15.5% in 2019, according to the NCSM. This increase has placed significant pressure on the country’s dialysis infrastructure, with the number of Malaysians requiring dialysis more than tripling over the past two decades. These trends underscore the necessity for preventative strategies that identify risk factors before further complications develop.
The proposed co-screening model suggests that incorporating standardised CRM risk assessments into routine health checks could streamline the diagnostic process. By creating stronger referral and follow-up systems, health systems can ensure that patients who screen positive for one risk factor are automatically evaluated for related conditions. This systemic integration is intended to reduce the reliance on reactive care and move toward proactive, long-term management.
Challenges in Implementation and Future Steps
Transitioning to an integrated model requires more than just screening protocols; it necessitates a shift in how referral systems and follow-up care are administered. Fragmented referral systems and inconsistent follow-up can lead to delayed treatment after abnormal screening results. The NCSM argues that early detection must be matched by coordinated follow-up and long-term care to improve outcomes and reduce the growing burden of chronic disease.
The advocacy for national co-screening emphasizes that early detection is only the first step. To be effective, screening programs must be paired with sustainable long-term care models. As public health agencies evaluate these proposals, the focus remains on building a framework that can handle the volume of patients while maintaining the quality of care necessary to reduce the long-term burden on the healthcare system.
As of the most recent public discourse, health stakeholders are continuing to discuss the integration of these protocols into national health policy. Future updates regarding the expansion of these programs will depend on ongoing dialogue between public health organizations and government health ministries. Readers are encouraged to monitor updates from local health authorities regarding the availability of integrated screening initiatives and to consult with their primary care physicians about their own cardiovascular, renal, and metabolic health.
Related reading